Expand PHAT Menu
PHAT MENU

PHAT Latest Press Releases

-- January 7, 2026 --

Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants Globe Newswire 10:33 PM
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Globe Newswire 4:05 PM
Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 4:01 PM

-- November 4, 2025 --

Phathom Pharmaceuticals Announces First Patient Dosed in Phase 2 Study of VOQUEZNA (vonoprazan) in Eosinophilic Esophagitis (EoE) Globe Newswire 8:00 AM

-- November 3, 2025 --

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences Globe Newswire 7:59 AM

-- October 30, 2025 --

Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- October 25, 2025 --

Phathom Pharmaceuticals Announces Publication of Data from Phase 3 pHalcon-NERD-301 Study Showing VOQUEZNA (vonoprazan) Improved Nocturnal GERD Symptoms in Patients with Non-Erosive Reflux Disease Globe Newswire 9:59 AM

-- October 23, 2025 --

Phathom Pharmaceuticals to Highlight VOQUEZNA (vonoprazan) at the American College of Gastroenterology (ACG) 2025 Annual Scientific Meeting Globe Newswire 8:00 AM

-- October 20, 2025 --

Phathom Pharmaceuticals to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, October 30, 2025 Globe Newswire 8:00 AM

-- October 6, 2025 --

Phathom Pharmaceuticals Appoints Sanjeev Narula as Chief Financial and Business Officer Globe Newswire 8:00 AM

-- August 25, 2025 --

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences Globe Newswire 7:59 AM

-- August 20, 2025 --

Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder's Ownership Following Administrative Change to 13D Filing Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes